BLOG: Angela Culhane, our CEO, discusses in further detail the reasons behind this change in figures announced last week.
For the first time, more men are dying from prostate cancer each year than women are from breast cancer, making the male disease the third biggest cancer killer in the UK. We find out why and urge the public to March for Men with us this summer to help curb the trend.
US scientists experimenting on mice have discovered that a high-fat diet as well as genetics can determine whether localised prostate cancer spreads to other parts of the body. Dr Sophie Lutter takes an in-depth look at the science and what it could mean for men with the disease.
In recent media campaigns, we’ve been using the statistic that one man dies of prostate cancer every 45 minutes and men are taking notice. But what does it mean for an individual man? We explain the facts behind the figure.
BLOG: Dr Ian Le Guillou looks back at some of 2017's highlights from the world of prostate cancer research – all of which we had a hand in bringing about thanks to your generous donations.
More news from the National Cancer Research Institute (NCRI) Cancer Conference this week comes from researchers at the Institute of Cancer Research (ICR) in London. They’ve carried out a large-scale analysis of patient data from another trial to predict which men are most likely to experience unpleasant side effects after radiotherapy.
New research presented at the National Cancer Research Institute (NCRI) Cancer Conference shows men with naturally low levels of testosterone are less likely to develop prostate cancer. But the study has also raised some difficult questions.
Our new precision medicine research programme aims to tailor treatments based on the genetic make-up of a man’s prostate cancer. The results could extend the lives of more than 9,000 men with advanced disease every year in the UK.
Hayley Yarnley knows how much our new precision medicine research programme could have helped her father, Bernie, who died from advanced prostate cancer last December. She describes how the births of her children kept him going during his treatment, and why he was convinced scientists would one day find a cure.
In this guest blog Dr Chris Armstrong – Marcher, Mo grower and ambitious researcher – explains what he hopes to achieve with the Travelling Prize Fellowship we’ve just awarded him and how this critical leg up the academic research ladder will benefit men with prostate cancer.